Table 1 Baseline characteristics of study patients
From: Cardiovascular determinants of prognosis in normotensive hemodialysis patients
Variables | Survivors (n = 100) | Non-cardiovascular death (n = 27) | Cardiovascular death (n = 18) |
|---|---|---|---|
Age (year) | 48.8 ± 13.0* | 67.3 ± 13.7 | 69.1 ± 8.3 |
Male gender,% | 53% | 61% | 55% |
Weight (kg) | 59.3 ± 10.5 | 60.4 ± 8.2 | 59.7 ± 9.7 |
Height (cm) | 161 ± 9 | 161 ± 7 | 158 ± 9 |
BMI (kg/m2) | 22.8 ± 3.3 | 23.3 ± 3.0 | 23.7 ± 2.8 |
Diabetes (%) | 4%* | 18%# | 41% |
History of cardiovascular disease (%) | 6%* | 29% | 31% |
Hypertension history (%) | 17.0 | 22.2 | 27.1 |
Previous hypertension duration (years) | 13.3 ± 4.7 | 12.6 ± 3.2 | 13.8 ± 5.0 |
Medications | |||
Vitamin D receptor agonists (%) | 15.1 | 22.0 | 18 |
Lipid lowering agents (%) | 28.3 | 22.2 | 20 |
Dialysis duration (days) | 2178 ± 2006 | 978 ± 1018 | 1508 ± 1124 |
Systolic BP (mmHg) | 114 ± 17 | 107 ± 19 | 116 ± 15 |
Diastolic BP (mmHg) | 66 ± 12 | 61 ± 10 | 68 ± 10 |
Pulse BP (mmHg) | 47 ± 9 | 46 ± 13 | 49 ± 11 |
Systolic BPavg (mmHg) | 126 ± 19 | 119 ± 19 | 131 ± 18 |
Diastolic BPavg (mmHg) | 75 ± 10 | 70 ± 9 | 76 ± 8 |
Pulse BPavg (mmHg) | 51 ± 10 | 49 ± 13# | 55 ± 13 |
Hematocrit (%) | 31.0 ± 4.2* | 30.0 ± 2.9 | 29.3 ± 2.7 |
Hemoglobin (g/L) | 103 ± 15 | 100 ± 11 | 100 ± 8 |
Kt/V | 1.56 ± 0.31 | 1.50 ± 0.18 | 1.44 ± 0.22 |
LVMI (g/height2.7) | 50.3 ± 14.1* | 51.6 ± 15.3# | 72.1 ±31.0 |
LV EF (%) | 71 ± 8* | 72 ± 13# | 62 ±17 |
Carotid IMT (μm) | 774 ± 166* | 875 ± 146# | 1015 ± 249 |
Carotid Augmentation Index (%) | 13.8 ± 20.3 | 14.5 ± 14.5 | 19.3 ± 20.6 |
Carotid Einc (kPa*103) | 0.39 ± 0.20 | 0.41 ± 0.26 | 0.45 ± 0.17 |
PWV (m/s) | 8.3 ± 3.0* | 10.3 ± 4.2# | 12.8 ± 2.2 |